Storage conditions：Short-term storage at 2~8℃, long-term storage at -20 ~ -80℃

Introduction/Overview

Liquidambaric lactone, CAS number 185051-75-6, is a natural compound isolated from plants that has attracted widespread attention in recent years due to its remarkable anti-inflammatory activity. Natural products, as important sources of drug discovery, offer rich chemical space for new drug development due to their structural diversity and biological activity. As a class of lactone compounds, Lulutonolide demonstrates regulatory capabilities over various inflammation-related targets, especially in modulating cytokines and signaling pathways. With the increasing incidence of inflammation-related diseases, the search for efficient and safe anti-inflammatory drugs has become a focus of modern pharmacological research. The study of Lulutonolide provides new ideas and potential candidate molecules for the development of natural anti-inflammatory drugs.

This paper aims to systematically review the chemical structure and physicochemical properties of Lulutonolactone, plant origin and extraction methods, pharmacological activity and mechanism of action, druggability evaluation, and pharmacokinetic characteristics. Combined with its clinical application prospects, it comprehensively assesses its potential as an anti-inflammatory drug, providing theoretical basis and reference for subsequent basic and applied research.

Chemical structure and physicochemical properties

The molecular formula of Lulutongolide is C_28H_36O_7, with a molecular weight of 468.6780, making it a natural product of the lactone class. Its structural features include typical lactone ring systems and polyhydroxyl substituents, which give it high chemical and biological activity. The lactone ring in the molecular structure is not only a key group for its biological activity, but also plays a decisive role in the stability of the molecule and its ability to bind to targets.

In terms of physicochemical properties, Lulutonolide has a LogP value of 5.9417, indicating strong lipophilucity, which helps it penetrate lipid membranes, especially the blood-brain barrier (BBB) with high penetration ability, supporting its potential application in central nervous system-related inflammatory diseases. Its topological polar surface area (TPSA) is 55.9 Ų, and moderate polarity facilitates molecular binding and distribution of biological targets. Its extremely low water solubility (0.0006 mg/mL) suggests limited solubility in the aqueous phase, which may affect oral absorption and bioavailability.

Safety evaluation showed that lulutonolide did not inhibit hERG channels, reducing its cardiotoxicity risk, and the Ames test result was zero, indicating it is not mutagenic and has relatively high safety.

Plant Origins and Extraction Methods

Lulutongolide is mainly isolated from the genus Liquidambar, a plant in the Hamamelidaceae family, which is widely distributed in East Asia and North America and has traditionally been used to treat rheumatism, inflammation, and skin diseases. Although the content of lulutonolide in plants is not high, its unique biological activity makes it a key research focus.

The extraction method typically uses organic solvent extraction combined with chromatography separation technology. Common extraction solvents include ethanol, methanol, and ethyl acetate, which can effectively dissolve fat-soluble components. The extraction process generally includes drying and crushing plant materials, solvent extraction and concentration, liquid chromatography separation and purification of the crude extract. High-performance liquid chromatography (HPLC) and mass spectrometry (MS) technologies are used for purity detection and structural confirmation.

In recent years, green extraction technologies such as supercritical CO_2 extraction and microwave-assisted extraction have also been attempted to be applied to the extraction of Lulutongolide, aiming to improve extraction efficiency and purity, reduce the use of organic solvents, and align with the environmental trend of modern natural product extraction.

Pharmacological activity research

Pharmacological activity studies of lulutonolide focus on its anti-inflammatory effects, covering both in vitro cell models and in vivo animal models. Multiple studies have shown that Lulutonolide can significantly inhibit the production and release of inflammatory mediators, reducing inflammatory responses.

At the cellular level, lulutonolide exhibits inhibitory effects on inflammation-related cells such as macrophages and fibroblasts, reduces the expression of pro-inflammatory cytokines such as IL-6 and TNF-α, and weakens the transmission of inflammatory signals. Its inhibition of the inflammatory mediator synthases PTGS1 (COX-1) and PTGS2 (COX-2) further reduces prostaglandin production and alleviates inflammatory symptoms.

In animal experiments, Lulutonolactone demonstrated significant anti-inflammatory effects in various inflammatory models (such as mouse plantar swelling and arthritis models), reducing tissue swelling, infiltration of inflammatory cells, and tissue damage. Additionally, lulutonolide also modulates TRPV1 and TRPA1 channels related to neuroinflammation, suggesting its potential value in neuroinflammation and pain management.

Mechanism of action and molecular targets

The anti-inflammatory mechanism of lulutonolide involves multiple signaling pathways and various molecular targets, mainly including:

1. IL-6/STAT3 pathway
   IL-6, as an important pro-inflammatory cytokine, promotes inflammatory responses by activating the STAT3 signaling pathway. Lulutonolide can inhibit IL-6 expression and STAT3 phosphorylation, block signal transduction, and reduce the transcription activity of pro-inflammatory genes.

2. NF-κB signaling pathway
   NF-κB is a core transcription factor regulating inflammatory responses. Lulutonolactone inhibits NFKB1 activation, reduces the synthesis of inflammatory mediators, and alleviates inflammatory responses.

3. CASP1 (Caspase-1)
   CASP1 participates in the activation of inflammasomes, promoting the maturation of pro-inflammatory cytokines such as IL-1β. Lulutonolide reduces inflammatory responses mediated by inflammasomes by inhibiting CASP1 activity.

4. TRPV1 and TRPA1 channels
   These two transient receptor potential channels play important roles in the transmission of pain and inflammatory signaling. The regulatory effect of lulutonolide helps alleviate neurotic inflammation and pain.

5. NOS2 (Induced nitric oxide synthase)
   NOS2 catalyzes nitric oxide production, and excess NO participates in inflammatory responses. Lulutonolactone inhibits NOS2 expression, lowers NO levels, and alleviates inflammation.

6. PTGS1 and PTGS2 (COX-1 and COX-2)
   Inhibiting the activity of these two enzymes, reducing prostaglandin synthesis, and relieving inflammation and pain.

In summary, Lulutongolide exerts its anti-inflammatory effect through multi-target and multi-pathway synergistic effects, demonstrating its advantages as a multi-target drug.

Druggability evaluation and pharmacokinetics

Druggability evaluation is a crucial step in the development of natural product drugs. The physicochemical parameters of Lulutonolide show high lipid solubility (LogP 5.94), which facilitates cell membrane penetration and blood-brain barrier penetration, supporting its potential application in central nervous system inflammation. Its TPSA is moderate, meeting the pharmacokinetic requirements of oral drugs.

Its extremely low water solubility may limit its oral absorption and bioavailability, so drug formulation techniques (such as nanocarriers and liposome encapsulation) are needed to improve solubility and stability. In terms of safety, it has no hERG inhibitory or mutagenic properties, laying the foundation for clinical application.

Pharmacokinetics, there are few studies, but its high lipid solubility and blood-brain barrier permeability suggest its wide distribution in the body, especially accumulation in brain tissue. Metabolic pathways may involve oxidation and reduction reactions in the liver, with excretion mainly via bile and urine. In the future, systematic in vivo pharmacokinetic and toxicological studies are needed to clarify their metabolic kinetics and safe dosage ranges.

Prospects and outlooks for clinical applications

Given the inhibitory effects of lulutonolide on various inflammation-related targets, especially its regulatory role in key inflammatory pathways such as IL-6/STAT3 and NF-κB, it has broad application prospects in the treatment of rheumatoid arthritis, inflammatory bowel disease, neuroinflammation, and related pain diseases.

Additionally, its excellent blood-brain barrier penetration makes it a potential candidate for treating inflammatory diseases of the central nervous system, such as multiple sclerosis and Alzheimer's-related inflammation. In the future, modern drug design technologies can be combined to optimize their structure, improve water solubility and bioavailability, and develop them into oral or injectable formulations.

By combining modern molecular biology and medicinal chemistry approaches, we can deeply analyze their mechanisms of action and molecular targets, helping to discover more indications and combination drug strategies. At the same time, conducting systematic preclinical safety evaluations and clinical trials is a key step in promoting clinical translation.

Conclusion

Lulutongolide, a natural lactone compound with significant anti-inflammatory activity, demonstrates great potential as a novel anti-inflammatory drug due to its multi-target regulatory capability and excellent druggability. Although research into its pharmacokinetics and clinical applications is still in its early stages, its unique molecular structure and broad bioactivity provide valuable examples for pharmacological research of natural products.

In the future, efforts should be made to optimize extraction processes, conduct in-depth pharmacological analyses, and systematically study safety and pharmacokinetics, promote the transformation of Lulutonolide from laboratory research to clinical application, support the innovative development of natural anti-inflammatory drugs, and meet the urgent clinical demand for efficient and safe anti-inflammatory drugs.